PPCM PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS MÉDICAS FACULDADE DE MEDICINA Teléfono/Ramal: 32141857

Banca de QUALIFICAÇÃO: LILYANA WALESKA NUNES ALBUQUERQUE

Uma banca de QUALIFICAÇÃO de MESTRADO foi cadastrada pelo programa.
STUDENT : LILYANA WALESKA NUNES ALBUQUERQUE
DATE: 15/08/2022
TIME: 16:00
LOCAL: meet.google.com/bra-gwec-gjw
TITLE:

Development of a new diagnostic method and in vitro evaluation of a new therapeutic strategy for leishmaniasis


KEY WORDS:

Leishmaniasis; New diagnostic methods; Acoustofluidics; New drugs; naphthoquinones; Patent Review.


PAGES: 100
BIG AREA: Ciências da Saúde
AREA: Farmácia
SUMMARY:

Introduction: Leishmaniasis is a neglected disease that, despite its epidemiological importance, still has limitations in terms of diagnosis, either because of the gold standard using an invasive biological sample collection method, or because of the variation in sensitivity, requirement of laboratory structure, highly qualified technicians. or high cost of other methods used. Objective: The present study aims to carry out a technological prospection of patents that indicate new immunodiagnostic methods for human tegumentary leishmaniasis in the last 10 years, aiming at diagnostic alternatives with a greater degree of sensitivity and specificity, of easy utilization and lower cost.Methods: This review of patent literature used six patent databases: The LENS, WIPO, EPO, USPTO, Patent Inspiration, Google patents and INPI.Results: 630 patents were analyzed, of which 13 were selected according to combinations of descriptors and study criteria. The information gathered here covered the main characteristics of the immunodiagnostic methods evaluated. Conclusion: In conclusion, the present prospective study indicated the biotechnological advances in the immunodiagnosis of cutaneous leishmaniasis in the last decade, especially in Brazil, which has the largest number of patents on new methods for the immunodiagnosis of cutaneous leishmaniasis. However, despite being a neglected disease, in the last three years no patent document on the subject was found, which raises a concern about the diagnosis of leishmaniasis.


BANKING MEMBERS:
Presidente - 2272670 - ALINE CAVALCANTI DE QUEIROZ
Interna - 2269479 - CAROLINNE DE SALES MARQUES
Externa à Instituição - MARIANA DA SILVA SANTOS
Notícia cadastrada em: 10/08/2022 17:55
SIGAA | NTI - Núcleo de Tecnologia da Informação - (82) 3214-1015 | Copyright © 2006-2024 - UFAL - sig-app-2.srv2inst1 31/10/2024 21:05